Search
Research
Food AllergyFood allergies have become more common in our community, with up to one in ten young children now affected. Reactions can range from mild hives to life threatening anaphylaxis and breathing difficulties. The most common food allergies are to egg, peanut, tree nuts, cow’s milk, fish, shellfish, sesame, wheat and soy.
Leaders in the not-for-profit, research, philanthropy and business sectors have joined forces to shine a light on the human and economic benefits of early support for Australian children.
World-first findings from the collaborative REACT study – a joint project between The Kids, PCH, UWA and Curtin University – have led to the asthma medication Ventolin being routinely given to paediatric patients before tonsillectomy surgery to prevent respiratory complications.
Trans or gender diverse young people are working with The Kids researchers to come up with resources that will provide better support to parents.
Discover more about some of the broad topics and areas of research that The Kids Research Institute Australia are involved in.
A ground-breaking new app developed by The Kids researchers may soon make exercising safer for young people with type 1 diabetes.
In early 2021, The Kids Research Institute Australia researcher Dr Amy Finlay-Jones led a global team in trying to answer that question to help better prioritise mental health spending.
Research
Implementation Fidelity of a Smartphone Application for Population-Based General Movement Assessment: The Early Moves StudyTo describe the infant and maternal characteristics of the Early Moves cohort and to assess representativeness to the general population, and to evaluate the implementation fidelity of an application-based collection of General Movement Assessment (GMA) videos at writhing and fidgety age.
Research
Population pharmacokinetics of penicillin G: insights into increased clearance at low concentrations to guide development of improved long-acting formulations for syphilisAlthough benzylpenicillin (penicillin G) is listed by the World Health Organization as an Essential Medicine, dose optimization is a persistent challenge, especially for long-acting intramuscular formulations. Maintaining sustained antibiotic exposure at target concentrations is crucial for secondary chemoprophylaxis of rheumatic heart disease and treatment of syphilis.